newsfilter
← Latest News
GlobeNewswire·

ContraFect Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Update

YONKERS, N.Y., March 24, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new med